Ritva Kauppinen‐Mäkelin
- Endocrinology, Diabetes and Metabolism top 2%
- Surgery
- Molecular Biology
- Hematology top 10%
- Pathology and Forensic Medicine top 10%
- Co-authors
- Eliisa LöyttyniemiMatti VälimäkiTimo SaneUlf‐Håkan StenmanPirjo NuutilaHelene MarkkanenTapani EbelingPia Jaatinen
- Topics
- Pituitary Gland Disorders and Treatments (5 papers)Growth Hormone and Insulin-like Growth Factors (4 papers)Ophthalmology and Eye Disorders (3 papers)
- Partner nations
- FinlandUnited StatesIsrael
In The Last Decade
Ritva Kauppinen‐Mäkelin
10 papers receiving 860 citations
Peers
Comparison fields: 5 of 65
- Endocrinology, Diabetes and Metabolism 601
- Surgery 197
- Molecular Biology 152
- Hematology 144
- Pathology and Forensic Medicine 134
Countries citing papers authored by Ritva Kauppinen‐Mäkelin
This map shows the geographic impact of Ritva Kauppinen‐Mäkelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritva Kauppinen‐Mäkelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritva Kauppinen‐Mäkelin more than expected).
Fields of papers citing papers by Ritva Kauppinen‐Mäkelin
This network shows the impact of papers produced by Ritva Kauppinen‐Mäkelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritva Kauppinen‐Mäkelin. The network helps show where Ritva Kauppinen‐Mäkelin may publish in the future.
Co-authorship network of co-authors of Ritva Kauppinen‐Mäkelin
This figure shows the co-authorship network connecting the top 25 collaborators of Ritva Kauppinen‐Mäkelin. A scholar is included among the top collaborators of Ritva Kauppinen‐Mäkelin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ritva Kauppinen‐Mäkelin. Ritva Kauppinen‐Mäkelin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 114 | |
| 2 | 81 | |
| 3 | 47 | |
| 4 | 38 | |
| 5 | 207 | |
| 6 | 72 | |
| 7 | 34 | |
| 8 | 157 | |
| 9 | 141 | |
| 10 | Apolipoprotein B gene 3'hypervariable region polymorphism and myocardial infarction in dyslipidemic Finnish men participating in a primary prevention trial | 5 |
About Ritva Kauppinen‐Mäkelin
Ritva Kauppinen‐Mäkelin is a scholar working on Endocrinology, Diabetes and Metabolism, Hematology and Pathology and Forensic Medicine, having authored 10 papers that have together received 896 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (5 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Ophthalmology and Eye Disorders (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (601 citations), Internal Medicine (60 citations) and Hematology (144 citations). Ritva Kauppinen‐Mäkelin has collaborated with scholars based in Finland, United States and Israel. Frequent co-authors include Eliisa Löyttyniemi, Matti Välimäki, Timo Sane, Ulf‐Håkan Stenman, Pirjo Nuutila, Helene Markkanen, Tapani Ebeling, Pia Jaatinen, Markku Kaste and Heikki Palomäki. Their work appears in journals such as Nature Genetics, The Journal of Clinical Endocrinology & Metabolism and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.